Latin America Carbapenem Market Size & Outlook, 2022-2030
Related Markets
Latin America carbapenem market highlights
- The Latin America carbapenem market generated a revenue of USD 167.3 million in 2022.
- The market is expected to grow at a CAGR of 5.7% from 2023 to 2030.
- In terms of segment, meropenem was the largest revenue generating drug class in 2022.
- Meropenem is the most lucrative drug class segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2023 to 2030.
Latin America data book summary
| Market revenue in 2022 | USD 167.3 million |
| Market revenue in 2030 | USD 259.8 million |
| Growth rate | 5.7% (CAGR from 2022 to 2030) |
| Largest segment | Meropenem |
| Fastest growing segment | Meropenem |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Meropenem, Imipenem, Ertapenem, Others Drug Class |
| Key market players worldwide | Menarini Group, Pfizer Inc, Sun Pharmaceutical Industries, Lupin, Aurobindo Pharma, Merck & Co Inc, Venus Group |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.6% of the global carbapenem market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,364.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Carbapenem Market Scope
Carbapenem Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Menarini Group | View profile | 1001-5000 | Firenze, Toscana, Italy, Europe | http://www.menarini.com |
| Sun Pharmaceutical Industries | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://www.sunpharma.com |
| Aurobindo Pharma | View profile | 10001+ | Hyderabad, Andhra Pradesh, India, Asia | http://aurobindo.com |
| Venus Group | View profile | 101-250 | Foothill Ranch, California, United States, North America | https://www.venusgroup.com/ |
| Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
Latin America carbapenem market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to carbapenem market will help companies and investors design strategic landscapes.
Meropenem was the largest segment with a revenue share of 54.81% in 2022. Horizon Databook has segmented the Latin America carbapenem market based on meropenem, imipenem, ertapenem, others drug class covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Latin America carbapenem market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America carbapenem market databook
-
Our clientele includes a mix of carbapenem market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America carbapenem market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America carbapenem market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America carbapenem market report size, by country, 2018-2030 (US$M)
Latin America Carbapenem Market Share, 2022 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
